Brain bleed patients: could the right IV fluid save more lives?

NCT ID NCT04043598

Recruiting now Disease control Sponsor: Insel Gruppe AG, University Hospital Bern Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 320 adults who had a brain bleed (subarachnoid hemorrhage) to see if the type of IV fluid they receive affects their recovery. The goal is to find out if a fluid with a specific salt content can reduce dangerous complications like blood vessel spasms and brain swelling. Participants are randomly assigned to one of two common IV fluids, and researchers track their outcomes in the hospital.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness subarachnoid hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS INFUSION FLUID SODIUM DISORDER SUBARACHNOID HEMORRHAGE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Intensive Care Medicine
RECRUITING

Geneva, 1205, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••
Department of Intensive Care, Bern University Hospital and University of Bern, Bern, Switzerland
RECRUITING

Bern, 3010, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••
Department of perioperative Intensive Care Medicine
RECRUITING

Sankt Gallen, Canton of St. Gallen, 9007, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.